Study finds decisiondx®-melanoma significantly improves the risk stratification of patients with stage i melanoma compared to american joint committee on cancer 8th edition staging

Friendswood, texas--(business wire)---- $cstl #ajcc8--castle announced a study showing decisiondx-melanoma provided significantly better risk stratification than ajcc8 staging in stage i melanoma.
CSTL Ratings Summary
CSTL Quant Ranking